Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, ...

Perceptive eClinical, part of Perceptive Group, is pleased to announce the launch of ClinPhone 5, a ground-breaking new ...

Daré will host a conference call and live webcast today, November 14, 2024, at 4:30 p.m. Eastern Time to review financial ...

November 14, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biotechnology company exploring new pathways towards a cancer-free future by using its INTASYL ® siRNA gene silencing ...

NorthStar to provide Cellectar with non-carrier-added Ac-225 for its expanded portfolio of clinical programsFLORHAM PARK, N.J., Nov. 14, 2024 ...

AdventHealth claims top spot; Cleveland Clinic elevated to Masters Category joining Mayo Clinic and Intermountain Healthcare.

Existing supply chains for medical radioisotopes are often strained ... patient enrollment and the completion of clinical studies, the FDA review process and other government regulation, our ability ...

The rise of antibody therapeutics is transforming drug discovery, providing highly specific treatments for complex diseases ...

A new study has shed light on the health risks faced by people who stop using weight-loss medications Ozempic or Wegovy.

Daré Bioscience, Inc. ( NASDAQ: DARE) Q3 2024 Earnings Conference Call November 14, 2024 4:30 PM ET MarDee Haring-Layton - CAO Sabrina Martucci Johnson - President and CEO ...

Metsera has brought in over $500m in funding in just seven months as it looks to enter the competitive weight loss arena.